-transparent.png){kind=logo}
Gastric acid produced by the parietal cells has a significant role in a variety of gastrointestinal diseases, such as duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease. We address acid production by the parietal cell and the pharmacological means to control gastric acid secretion. The physiology of parietal cell acid secretion is reviewed. The role of acid-suppressive therapy with histamine H2 antagonists and omeprazole in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease is discussed. Pharmacology, side-effect profile, and dosage requirements of the histamine H2 antagonists and omeprazole are outlined.
Related Publications
A M Zfass, and
L McHenry, and
A J Sanyal
July 1988,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A M Zfass, and
L McHenry, and
A J Sanyal
January 1986,
Postgraduate medical journal,
A M Zfass, and
L McHenry, and
A J Sanyal
October 1992,
Bioscience reports,
A M Zfass, and
L McHenry, and
A J Sanyal
January 1982,
Revue medicale de Liege,
A M Zfass, and
L McHenry, and
A J Sanyal
February 2003,
Digestive diseases and sciences,
A M Zfass, and
L McHenry, and
A J Sanyal
June 1988,
Brain research bulletin,
A M Zfass, and
L McHenry, and
A J Sanyal
December 1963,
Lancet (London, England),
A M Zfass, and
L McHenry, and
A J Sanyal
July 1971,
Proceedings of the Royal Society of Medicine,
A M Zfass, and
L McHenry, and
A J Sanyal
March 1985,
Naunyn-Schmiedeberg's archives of pharmacology,
A M Zfass, and
L McHenry, and
A J Sanyal
November 1960,
Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten,
